NorthView Acquisition Stock Price, News & Analysis
PFSA
NASDAQ
Company Description
Welcome to the overview page for NorthView Acquisition (PFSA), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$8,196,876
Net Income (TTM)
$1.53
$501,614
Operating Cash Flow
0.04
$967,084
—
Revenue (TTM)
Upcoming Events
JAN
01
January 1, 2026 - April 30, 2026
Product
Insight portal launch
Launch of AI-powered biochemistry monitoring portal across EEA under CE Mark
JAN
01
January 1, 2026 - March 31, 2026
Product
EU Lumee platform launch
Launch of Lumee tissue oxygen monitoring platform in Europe
MAY
01
May 1, 2026 - August 31, 2026
Regulatory
FDA submission for Lumee
U.S. FDA submission for Lumee tissue oxygen platform
JAN
01
January 1, 2027 - December 31, 2027
Product
Lumee platform commercialization
Commercial launch of Lumee tissue oxygen monitoring platform in U.S.
MAY
01
May 1, 2027 - August 31, 2027
Product
Glucose platform commercialization
Commercialization of glucose monitoring platform
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of NorthView Acquisition (PFSA)?
The current stock price of NorthView Acquisition (PFSA) is $0.321 as of October 13, 2025.
What is the market cap of NorthView Acquisition (PFSA)?
The market cap of NorthView Acquisition (PFSA) is approximately 13.4M. Learn more about what market capitalization means .
What is the net income of NorthView Acquisition (PFSA)?
The trailing twelve months (TTM) net income of NorthView Acquisition (PFSA) is $8,196,876.
What is the earnings per share (EPS) of NorthView Acquisition (PFSA)?
The diluted earnings per share (EPS) of NorthView Acquisition (PFSA) is $1.53 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of NorthView Acquisition (PFSA)?
The operating cash flow of NorthView Acquisition (PFSA) is $501,614. Learn about cash flow.
What is the current ratio of NorthView Acquisition (PFSA)?
The current ratio of NorthView Acquisition (PFSA) is 0.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of NorthView Acquisition (PFSA)?
The operating income of NorthView Acquisition (PFSA) is $967,084. Learn about operating income.